My answer to Amatuer17's FUD about Phase 3 taking

Quote:

---

Since you like to compare things,

Oritavancin Phase 2 completion date: May 2008

https://clinicaltrials.gov/ct2/show/NCT005145...amp;rank=1

Oritavancin Phase 3 start date: December 2010

https://clinicaltrials.gov/ct2/show/NCT012527...amp;rank=1

SPA application date: March 26, 2010

http://www.accessdata.fda.gov/drugsatfda_docs...00MedR.pdf

SPA agreement date: November 30, 2010

http://www.firstwordpharma.com/node/809053#axzz4ABcs9svI

Both Oritavancin and Brilacidin are single-dose treatment for ABSSSI with QIDP designation.

---